A handful of states are targeting the technology at the same time the Trump administration is cutting research funding and ...

VOV.VN - Pfizer Vietnam Company Limited (Pfizer VN) and Vietnam Vaccine Joint Stock Company (VNVC) signed a Memorandum of ...

Key Takeaways The COVID vaccine does not increase the risk of birth defects in pregnant womenResearchers found no risk in ...

In early 2021, individual investors and institutions hurled money at Moderna stock as if future growth were unlimited.

The National Institutes of Health are the world’s largest funder of medical research, distributing $35 billion in in grants ...

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit.

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine technology ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

According to Pfizer and BioNTech, this is the first time that an mRNA-based flu vaccine has started a phase 3 efficacy trial. Its rival Moderna said earlier this month, however, that it has ...

Vaccine hesitancy was rising even before COVID-19 emerged – but the pandemic exacerbated the trend. More kindergartners are ...